# Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors

> **NCT04551144** · — · TERMINATED · sponsor: **St. Louis University** · enrollment: 4 (actual)

## Conditions studied

- Gender Incongruence
- Transgenderism

## Interventions

- **DRUG:** testosterone cypionate
- **DRUG:** Estradiol Valerate

## Key facts

- **NCT ID:** NCT04551144
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-06
- **Primary completion:** 2023-01-18
- **Final completion:** 2023-01-18
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** lack of recruitment
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04551144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04551144, "Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04551144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
